Genetic characterization of hepatitis C virus strains in Estonia: Fluctuations in the predominating subtype with time

Journal of Medical Virology

Volumn 79, Issue 4, 2007, Pages 374-382

  Tallo, Tatjana ^a,b,c   Norder, Helene ^b,c   Tefanova, Valentina ^a   Krispin, Tõnu ^d   Schmidt, Jelena ^e   Ilmoja, Madis ^f   Orgulas, Karen ^g   Pruunsild, Kaije ^g   Priimägi, Ludmilla ^a   Magnius, Lars O ^b,c  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF TARTU   (Estonia)

^e Ida Viru Central Hospital   (Estonia)

^f WEST TALLINN CENTRAL HOSPITAL   (Estonia)

^g TALLINN CHILDREN S HOSPITAL   (Estonia)

Author keywords

Genotypes; Hepatitis C virus; Phylogenetic analysis; Shift

Indexed keywords

PROTEIN 5B; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; CHILD; ESTONIA; FEMALE; GENOTYPE; HEALTH CARE PERSONNEL; HEPATITIS C VIRUS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RISK FACTOR; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TYPING;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; BLOOD DONORS; ESTONIA; FEMALE; HEPACIVIRUS; HEPATITIS C; HOSPITALS; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PATIENTS; PERSONNEL, HOSPITAL; RISK FACTORS; RNA, VIRAL; SPECIES SPECIFICITY; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 33847612815     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20828     Document Type: Article

References (42)

1. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G. 2005. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76:327-332.
2. Bell H, Helium K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P. 1996. Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group. Scand J Infect Dis 28:357-359.
3. Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P. 2002. Epidemiological changes in hepatitis C virus genotypes in France: Evidence in intravenous drug users. J Viral Hepat 9:62-70.
4. Bukh J, Purcell RH, Miller RH. 1993. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 90:8234-8238.
5. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. 1999. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22-26.
6. Felstenstein J. 1993. PHYLIP: Phylogeni Inference Package; Version 3.52c. Seattle, WA: University of Washington.
7. Ferenci P. 2004. Predictors of response to therapy for chronic hepatitis C. Semin Liver Dis 24:25-31.
8. Feucht HH, Schroter M, Zollner B, Polywka S, Nolte H, Laufs R. 1997. The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b. J Infect Dis 175:685-688.
9. Garson JA, Ring C, Tuke P, Tedder RS. 1990. Enhanced detection by PCR of hepatitis C virus RNA. Lancet 336:878-879.
10. Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. 2001. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 20:41-47.
11. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomolov S, Magnius LO. 2001. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 65:517-524.
12. Kalinina O, Norder H, Mukomolov S, Magnius LO. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76:4034-4043.
13. Kuiken C, Combet C, Bukh J, Shin-I T, Deleage G, Mizokami M, Richardson R, Sablon E, Yusim K, Pawlotsky JM, Simmonds P. Los Alamos HIV Database Group. 2006. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 44:1355-1361.
14. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, Butterworth L, Cooksley G, Gish RG, Beaugrand M, Fay F, Fay O, Gonzalez JE, Martins RM, Dhumeaux D, Vanderborght B, Stuyver L, Sablon E, de Lamballerie X, Pawlotsky JM. 2006. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296-1303.
15. Nakano T, Lu L, Liu P, Pybus OG. 2004. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190:1098-1108.
16. Norder H, Bergstrom A, Uhnoo I, Alden J, Weiss L, Czajkowski J, Magnius L. 1998. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol 36:3066-3069.
17. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechet C. 1995. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 122:161-168.
18. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, et al. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679.
19. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, et al. 2005. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium: The GEMHEP GenoCII Study. J Viral Hepat 12:405-413.
20. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin-I T, Simmonds P, Smith D, Stuyver L, Weiner A. 1998. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143:2493-2503.
21. Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. 2000. Changes in the epidemiology of hepatitis C infection in Germany: Shift in the predominance of hepatitis C subtypes. J Med Virol 60:122-125.
22. Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P. 2002. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 36:1285-1291.
23. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. 2004. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol 74:246-252.
24. Schreier E, Roggendorf M, Driesel G, Hohne M, Viazov S. 1996. Genotypes of hepatitis C virus isolates from different parts of the world. Arch Virol Suppl 11:185-193.
25. Schröter M, Zollner B, Laufs R, Feucht HH. 2004. Changes in the prevalence of hepatitis C virus genotype among injection drug users: a highly dynamic process. J Infect Dis 190:1199-1200.
26. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. 2002. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 37:855-862.
27. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. 1993. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 67:5823-5832.
28. Shih CM, Chen CM, Chen SY, Lee YH. 1995. Modulation of the transsuppression activity of hepatitis C virus core protein by phosphorylation. J Virol 69:1160-1171.
29. Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Gavrilova IV, Akinfeeva LA, Rakova IG, Aleshina MV, Bukin VN, Orlovsky VG, Bespalov VS, Robertson BH, Netesov SV. 2005. Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol 77:382-389.
30. Simmonds P. 1999. Viral heterogeneity of the hepatitis C virus. J Hepatol Suppl 1 54-60.
31. Simmonds P. 2000. Hepatitis C virus genotypes. In: Liang TJ, Hoofnagle JH, (editors). Hepatitis C. London: Academic Press, pp 53-83.
32. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
33. Smith DB, Simmonds P. 1997. Review: Molecular epidemiology of hepatitis C virus. J Gastroenterol Hepatol 12:522-527.
34. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. 1997. The origin of hepatitis C virus genotypes. J Gen Virol 78:321-328.
35. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van HH, Maertens G. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102.
36. Tallo T, Lappalainen M, Tefanova V, Priimagi L. 2000. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia. Acta Virol 44:175-178.
37. Tefanova V, Tallo T, Kutsar K, Priimagi L. 2005. Current trends in the epidemiology of viral hepatitis B and C in Estonia. EpiNorth 3:57-61.
38. Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, Vasychova F, Widell A, Roggendorf M. 1997. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 53:36-40.
39. Wang YM, Ng WC, Lo SK. 1999. Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore. J Gastroenterol 34:481-485.
40. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, Seigneurin JM, Buffet C, Dhumeaux D. 1998. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 28:27-33.
41. Zeuzem S. 2004. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well? Ann Intern Med 140:370-381.
42. Zusinaite E, Krispin T, Raukas E, Kiiver K, Salupere R, Ott K, Ustina V, Zilmer K, Schmidt J, Sizemski L, Jaago K, Luman M, Ilmoja M, Prukk T, Ustav M. 2000. Hepatitis C virus genotypes in Estonia. APMIS 10:739-746.